Provided by Tiger Trade Technology Pte. Ltd.

Johnson & Johnson

242.49
-4.4200-1.79%
Post-market: 242.700.2100+0.09%19:55 EST
Volume:13.57M
Turnover:3.30B
Market Cap:584.23B
PE:21.98
High:246.88
Open:246.47
Low:240.28
Close:246.91
52wk High:246.96
52wk Low:141.50
Shares:2.41B
Float Shares:2.40B
Volume Ratio:1.31
T/O Rate:0.56%
Dividend:5.14
Dividend Rate:2.12%
EPS(TTM):11.03
EPS(LYR):11.03
ROE:35.03%
ROA:8.68%
PB:7.16
PE(LYR):21.98

Loading ...

Company Profile

Company Name:
Johnson & Johnson
Exchange:
NYSE
Establishment Date:
1886
Employees:
138200
Office Location:
One Johnson & Johnson Plaza,New Brunswick,New Jersey,United States
Zip Code:
08933
Fax:
- -
Introduction:
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company has a collaboration agreement with Stand Up To Cancer for research testing a combination of teclistamab and daratumumab to treat a rare disease AL amyloidosis. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

Directors

Name
Position
Jennifer L. Taubert
Executive Vice President, Worldwide Chairman, Innovative Medicine
Joaquin Duato
Chairman of the Board and Chief Executive Officer
Tim Schmid
Executive Vice President, Worldwide Chairman, MedTech
Daniel Pinto
Director
Eugene A. Woods
Director
H. Joly
Director
J. A. Doudna
Director
John Morikis
Director
M. A. Hewson
Director
M. A. Weinberger
Director
Mark B. McClellan
Director
Mary C. Beckerle
Director
Nadja Y. West
Director
Paula A. Johnson
Director

Shareholders

Name
Position
Joaquin Duato
Chairman of the Board and Chief Executive Officer
Joseph J. Wolk
Chief Financial Officer and Executive Vice President
Elizabeth Forminard
Chief Legal Officer and Executive Vice President
James Swanson
Chief Information Officer and Executive Vice President
John C. Reed
Executive Vice President, Innovative Medicine, R&D
Kathryn E. Wengel
Chief Technical Operations & Risk Officer and Executive Vice President
Kristen Mulholland
Chief Human Resources Officer and Executive Vice President
R. J. Decker Jr.
Controller and Chief Accounting Officer
Vanessa Broadhurst
Executive Vice President, Global Corporate Affairs